ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 968,25
0,12%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) Actualités

NUWE Newellis Inc

0,1705
-0,0355 (-17,23%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Newellis Inc NUWE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0355 -17,23% 0,1705 06:00:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,215 0,1674 0,232 0,18 0,206
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202415:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
01/5/202400:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
30/4/202422:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26/4/202415:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/4/202415:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
11/3/202422:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202415:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
06/3/202418:02EDGAR2Form 8-K - Current report
05/3/202414:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
27/2/202415:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22/2/202413:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
20/2/202423:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
20/2/202414:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
08/2/202423:19EDGAR2Form S-1/A - General form for registration of securities..
06/2/202415:07EDGAR2Form 8-K - Current report
06/2/202415:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
09/1/202423:30EDGAR2Form 8-K/A - Current report: [Amend]
08/1/202415:24EDGAR2Form 8-K - Current report
04/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202421:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
13/12/202322:05EDGAR2Form 8-K - Current report
28/11/202314:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
14/11/202322:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
07/11/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:15EDGAR2Form 8-K - Current report
07/11/202314:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
01/11/202321:15EDGAR2Form 8-K - Current report
01/11/202313:00GLOBENuwellis Announces Board of Directors Transition
31/10/202313:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
18/10/202322:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
17/10/202322:30EDGAR2Form 8-K - Current report
17/10/202322:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13/10/202314:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202314:30EDGAR2Form 8-K - Current report
10/10/202314:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
06/10/202322:50EDGAR2Form POS462C - Post-effective amendment to registration..
05/10/202315:27EDGAR2Form AW - Amendment Withdrawal Request
04/10/202323:29EDGAR2Form POS AM - Post-Effective amendments for registration..
02/10/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
29/9/202314:56EDGAR2Form S-1/A - General form for registration of securities..
11/9/202322:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
06/9/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/8/202322:56EDGAR2Form 8-K - Current report
08/8/202318:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:25EDGAR2Form 8-K - Current report
08/8/202314:15EDGAR2Form 8-K - Current report
08/8/202314:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08/8/202314:00GLOBENuwellis Announces Plan for CFO Transition

Dernières Valeurs Consultées

NASDAQ
NUWE
Newellis
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés